
Pharmacy student coming back to this one. NO SEMAGLUTIDE. end of story, will destroy everything you’ve worked towards. Tirzepatide is risky, and you’ll lose some. Reta looks promising, but not enough clinical data to see either way to be completely honest. In my opinion? Don’t. Maybe reta one day, but not today.
I think it could be right for some people, but only if like they're GOING to die from being extremely overweight very soon, and they haven't been able to lose on their own. Pharmaceutical industry pushed it on to everyone for no reason and i really think nobody needs it unless they're like 600+ Ib. It's like giving yourself temporary drug induced anorexia
Okay I just wanted to make sure that’s what you are talking about. This isn’t a GLP-3 however I can see how you think that. GLP-1 is glucagon-like-peptide one, so when someone says a GLP-1 drug, they mean that it is acting as an agonist the receptors that bind to the glucagon like receptor. Double and triple agonists still work on the GLP-1 pathway and mechanism, just attacking it from different areas and utilizing different parts of the pathway and different receptors